National Bowel Cancer Audit – adjuvant chemotherapy use in stage III colon cancer short report

Reports | Published: 13 Aug 2020

This short report aims to explore how best to capture adjuvant chemotherapy use with linked Hospital Episode Statistics Admitted Patient Care (HES-APC) and Systemic Anti-Cancer Therapy (SACT) datasets by evaluating:

  1. whether information from the datasets can be combined to reliably capture adjuvant chemotherapy use in stage III colon cancer patients and
  2. whether information from the datasets can be combined reliably to capture the number of cycles of adjuvant chemotherapy in stage III colon cancer patients.

You can read the full report by clicking on the link below. Please note you will be prompted to register your details so you can receive updates. You may skip the registration process if you prefer.

Don’t miss out. Sign up to be notified when this resource is updated and to receive updates about other related quality improvement resources, events and news from HQIP. Or you can  .


By continuing you agree to receive emails with updates and other information from HQIP and you are confirming you are over the age of 13.

Please read our privacy policy to understand how HQIP uses the information you provide, your use of HQIP’s website and your interaction with the marketing emails to improve the relevance of the communications we send you. You can unsubscribe at any time.

I have read and agree with the contents of the privacy policy.

National Bowel Cancer Audit – adjuvant chemotherapy use in stage III colon cancer short report